Trending...
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- New Online Board Game Sin of Angels Lets Outlaw Gangs Battle for LA Solo or With Friends
CHICAGO - illiNews -- The American Gastroenterological Association, founded in 1897 and widely regarded as the leading voice for gastroenterology professionals worldwide, has unveiled the inaugural class of its new incubator program, called "Improving GI Care," created in partnership with the healthcare innovation hub MATTER.
Selection into this cohort represents formal recognition from one of the field's most established medical societies that a startup's technology addresses a genuine, unmet need within digestive disease care. Eleven companies earned spots in this first-ever cohort, chosen from a competitive pool of applicants after a rigorous, multi-stage evaluation process.
Over six months, these startups will receive mentorship, strategic guidance, and access to MATTER's network of healthcare industry connections, culminating in a showcase event at Digestive Disease Week 2026 in Chicago, where they'll present progress to investors and potential partners.
Among the eleven selected startups is Neurogut, developer of the BioAnatoner System, a clinically validated biofeedback therapy device built to address major pelvic floor disorders. The device targets conditions including dyssynergic defecation (a common form of chronic constipation), along with both fecal and urinary incontinence. What distinguishes the BioAnatoner from competing solutions is its dual-use design: the system functions equally well in clinical settings and in patients' homes.
More on illi News
Given that pelvic floor disorders affect more than 100 million Americans yet remain chronically underserved by existing therapies, Neurogut's platform is positioned to fill a significant gap. Company leadership has indicated plans to bring the BioAnatoner to market during 2026, with an initial focus on scaling distribution across clinical networks before pursuing broader consumer accessibility.
Neurogut's clinical direction has benefited from guidance provided by Dr. Satish Rao, a professor of medicine at Augusta University who has spent decades researching anorectal disorders, motility, and biofeedback-based treatments. Dr. Rao is widely credited with pioneering biofeedback therapy techniques for dyssynergic defecation, and his research contributions have earned him multiple honors from the AGA itself, including its Distinguished Clinician Award and Masters Award for Outstanding Clinical Research.
His advisory involvement extends beyond Neurogut. He also serves as a scientific advisor for GI Transit, another company within this incubator cohort that is developing bionic diagnostic devices for the upper gastrointestinal tract. Having a researcher of Dr. Rao's caliber connected to multiple companies in the same cohort speaks to the depth of clinical expertise informing this year's selected startups, and underscores how closely academic gastroenterology and early-stage medical technology are now intertwined.
More on illi News
As the incubator program progresses toward its culmination next spring, Neurogut and its cohort peers will continue refining their offerings with support from AGA and MATTER's combined resources, working toward the shared goal of transforming digestive disease care for millions of patients nationwide.
Learn more at https://www.neurogut.com
Selection into this cohort represents formal recognition from one of the field's most established medical societies that a startup's technology addresses a genuine, unmet need within digestive disease care. Eleven companies earned spots in this first-ever cohort, chosen from a competitive pool of applicants after a rigorous, multi-stage evaluation process.
Over six months, these startups will receive mentorship, strategic guidance, and access to MATTER's network of healthcare industry connections, culminating in a showcase event at Digestive Disease Week 2026 in Chicago, where they'll present progress to investors and potential partners.
Among the eleven selected startups is Neurogut, developer of the BioAnatoner System, a clinically validated biofeedback therapy device built to address major pelvic floor disorders. The device targets conditions including dyssynergic defecation (a common form of chronic constipation), along with both fecal and urinary incontinence. What distinguishes the BioAnatoner from competing solutions is its dual-use design: the system functions equally well in clinical settings and in patients' homes.
More on illi News
- Chicago: Mayor Brandon Johnson Cuts Ribbon on Austin United Alliance Apartments, Bringing 78 Mixed-Income Homes to Austin's Soul City Corridor
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- Johnnie Mandela Releases THOUGHT in the Age of AI
- MAZ6R CLAN & Riviera Marketing: 9/11, 25 - Years Later - "A Creative Response to Tragedy!"
- CodeAutomation Expands U.S. Footprint to Meet Growing Demand for AI and Automation Solutions
Given that pelvic floor disorders affect more than 100 million Americans yet remain chronically underserved by existing therapies, Neurogut's platform is positioned to fill a significant gap. Company leadership has indicated plans to bring the BioAnatoner to market during 2026, with an initial focus on scaling distribution across clinical networks before pursuing broader consumer accessibility.
Neurogut's clinical direction has benefited from guidance provided by Dr. Satish Rao, a professor of medicine at Augusta University who has spent decades researching anorectal disorders, motility, and biofeedback-based treatments. Dr. Rao is widely credited with pioneering biofeedback therapy techniques for dyssynergic defecation, and his research contributions have earned him multiple honors from the AGA itself, including its Distinguished Clinician Award and Masters Award for Outstanding Clinical Research.
His advisory involvement extends beyond Neurogut. He also serves as a scientific advisor for GI Transit, another company within this incubator cohort that is developing bionic diagnostic devices for the upper gastrointestinal tract. Having a researcher of Dr. Rao's caliber connected to multiple companies in the same cohort speaks to the depth of clinical expertise informing this year's selected startups, and underscores how closely academic gastroenterology and early-stage medical technology are now intertwined.
More on illi News
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
As the incubator program progresses toward its culmination next spring, Neurogut and its cohort peers will continue refining their offerings with support from AGA and MATTER's combined resources, working toward the shared goal of transforming digestive disease care for millions of patients nationwide.
Learn more at https://www.neurogut.com
Source: Neurogut
0 Comments
Latest on illi News
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Patented NogginLOC Technology Offers an Innovative Approach to Helmet Fastening
- Mandeville Pests May Pose Serious Health Risks for Your Family
- City of Chicago Partners With Chicago River Swim to Re-Launch "The Big Jump," Expand Field to 750 Swimmers
- Mayor Brandon Johnson and Chicago Public Schools Extend Chicago Connected Program for 2026–27 School Year
- Hardwood Flooring vs Carpet Comparison: Premier Custom Hardwood Flooring Releases Ultimate Buyer's Guide
- The Kryder Law Group, LLC Recovers $1,350,000 in Two Motorcycle Accident Settlements
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Inkdnylon Expands Into Large-Volume Apparel, Uniform and Branded Merchandise Procurement
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Aerostratospheric Announces xSatellite Flight Layer And September 12 x1Albatross Engineering Test
- Indie Author & Publishing News Website Launches!
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
- Lake Norman Philharmonic - Free Community Concert
- Inkdnylon Custom Apparel Introduces INKDNYLON MADE for Original Apparel, Accessories and Product Collections
- New Online Board Game Sin of Angels Lets Outlaw Gangs Battle for LA Solo or With Friends
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range